Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00052039 |
Date of registration:
|
21/01/2003 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
|
Scientific title:
|
A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone |
Date of first enrolment:
|
April 2002 |
Target sample size:
|
0 |
Recruitment status: |
Terminated |
URL:
|
http://clinicaltrials.gov/show/NCT00052039 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Italy
| | | | | | | |
Contacts
|
Name:
|
Steven Porter, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
InterMune |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Pulmonary Fibrosis
|
Lung Disease
|
Intervention(s)
|
Drug: azathioprine
|
Drug: interferon-gamma 1b
|
Primary Outcome(s)
|
This study was terminated prior to enrollment.
[Time Frame: This study was terminated prior to enrollment.]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|